Now available ORSERDU™

ORSERDU™ (elacestrant) is an estrogen receptor antagonist indicated for treatment of postmenopausal women or adult men, with ERpositive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.

Please see full prescribing information here.